Results 221 to 230 of about 2,330,129 (358)

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

Serological evaluation of brucellosis in nomadic small ruminants in Southeastern Türkiye. [PDF]

open access: yesBMC Vet Res
Ötkün S   +4 more
europepmc   +1 more source

Committee on Regional Sections

open access: yesJournal of AOAC INTERNATIONAL, 1986
Raymond H Bowers   +6 more
openaire   +1 more source

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao   +7 more
wiley   +1 more source

Regional Committee decisions.

open access: yesEastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2015
Ahmad Basel, Al-Yousfi, Mazen, Malkawi
openaire   +3 more sources

Global brain banking challenges through the lens of Southeast Asia's inaugural brain bank. [PDF]

open access: yesFront Neurol
Martin P   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy